Artificial Intelligence
From Diagnostics World: By Deborah Borfitz March 7, 2024 | Biomedical engineers have a significant role to play in the development and optimization of liquid biopsies to further precision oncology. Although molecular...
CND Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a...
Nijmegen, Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn,...
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical (IHC) assays to provide increased accuracy and consistency in laboratory practices. Many of the...
Proscia: Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images CAMBRIDGE, Mass. and PHILADELPHIA – February 27, 2024 – Proscia®, a leading provider of digital and computational pathology...
From the Medriva Blog Revolutionizing Digital Pathology with Deep Learning In the rapidly evolving landscape of healthcare and medicine, artificial intelligence (AI) and deep learning (DL) techniques are emerging as transformative tools,...
